ID   KKCC2_HUMAN             Reviewed;         588 AA.
AC   Q96RR4; A8K7Q7; O94883; Q8IUG2; Q8IUG3; Q8N3I4; Q8WY03; Q8WY04; Q8WY05;
AC   Q8WY06; Q96RP1; Q96RP2; Q96RR3; Q9BWE9; Q9UER3; Q9UES2; Q9Y5N2;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   12-OCT-2022, entry version 185.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase kinase 2;
DE            Short=CaM-KK 2;
DE            Short=CaM-kinase kinase 2;
DE            Short=CaMKK 2;
DE            EC=2.7.11.17;
DE   AltName: Full=Calcium/calmodulin-dependent protein kinase kinase beta;
DE            Short=CaM-KK beta;
DE            Short=CaM-kinase kinase beta;
DE            Short=CaMKK beta;
GN   Name=CAMKK2; Synonyms=CAMKKB, KIAA0787;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2; 3; 4; 5 AND 6),
RP   FUNCTION, AND VARIANT SER-85.
RX   PubMed=11395482; DOI=10.1074/jbc.m011720200;
RA   Hsu L.-S., Chen G.-D., Lee L.-S., Chi C.-W., Cheng J.-F., Chen J.-Y.;
RT   "Human Ca2+/calmodulin-dependent protein kinase kinase beta gene encodes
RT   multiple isoforms that display distinct kinase activity.";
RL   J. Biol. Chem. 276:31113-31123(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain cortex;
RX   PubMed=9822657; DOI=10.1074/jbc.273.48.31880;
RA   Anderson K.A., Means R.L., Huang Q.-H., Kemp B.E., Goldstein E.G.,
RA   Selbert M.A., Edelman A.M., Fremeau R.T., Means A.R.;
RT   "Components of a calmodulin-dependent protein kinase cascade. Molecular
RT   cloning, functional characterization and cellular localization of
RT   Ca2+/calmodulin-dependent protein kinase kinase beta.";
RL   J. Biol. Chem. 273:31880-31889(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND FUNCTION IN PHOSPHORYLATION OF
RP   CAMK1D.
RX   PubMed=12935886; DOI=10.1016/s0014-5793(03)00817-2;
RA   Ishikawa Y., Tokumitsu H., Inuzuka H., Murata-Hori M., Hosoya H.,
RA   Kobayashi R.;
RT   "Identification and characterization of novel components of a
RT   Ca2+/calmodulin-dependent protein kinase cascade in HeLa cells.";
RL   FEBS Lett. 550:57-63(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7), AND VARIANT SER-85.
RC   TISSUE=Brain;
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [5]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 233-588 (ISOFORM 5), AND VARIANT SER-85.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 117-588 (ISOFORM 2), FUNCTION IN
RP   PHOSPHORYLATION OF CAMK1, AND TISSUE SPECIFICITY.
RX   PubMed=9662074; DOI=10.1007/bf02258368;
RA   Hsu L.-S., Tsou A.-P., Chi C.-W., Lee C.-H., Chen J.-Y.;
RT   "Cloning, expression and chromosomal localization of human Ca2+/calmodulin-
RT   dependent protein kinase kinase.";
RL   J. Biomed. Sci. 5:141-149(1998).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 254-588 (ISOFORM 7).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 338-533 (ISOFORM 2).
RA   Barrow I.K.-P., Boguski M.S., Touchman J.W., Spencer F.;
RT   "Full-insert sequence of mapped XREF EST.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-522 (ISOFORM 3), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-479 (ISOFORM 5), AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, AUTOPHOSPHORYLATION, PHOSPHORYLATION BY
RP   PKA, AND INDUCTION OF ISOFORM 1.
RX   PubMed=21957496; DOI=10.4161/rna.8.6.16691;
RA   Cao W., Sohail M., Liu G., Koumbadinga G.A., Lobo V.G., Xie J.;
RT   "Differential effects of PKA-controlled CaMKK2 variants on neuronal
RT   differentiation.";
RL   RNA Biol. 8:1061-1072(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-129; SER-495 AND
RP   SER-511, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-10; SER-85; TYR-123; LEU-127; THR-182
RP   AND HIS-492.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase belonging to a
CC       proposed calcium-triggered signaling cascade involved in a number of
CC       cellular processes. Isoform 1, isoform 2 and isoform 3 phosphorylate
CC       CAMK1 and CAMK4. Isoform 3 phosphorylates CAMK1D. Isoform 4, isoform 5
CC       and isoform 6 lacking part of the calmodulin-binding domain are
CC       inactive. Efficiently phosphorylates 5'-AMP-activated protein kinase
CC       (AMPK) trimer, including that consisting of PRKAA1, PRKAB1 and PRKAG1.
CC       This phosphorylation is stimulated in response to Ca(2+) signals (By
CC       similarity). Seems to be involved in hippocampal activation of CREB1
CC       (By similarity). May play a role in neurite growth. Isoform 3 may
CC       promote neurite elongation, while isoform 1 may promoter neurite
CC       branching. {ECO:0000250, ECO:0000269|PubMed:11395482,
CC       ECO:0000269|PubMed:12935886, ECO:0000269|PubMed:21957496,
CC       ECO:0000269|PubMed:9662074}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.17;
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin may relieve intrasteric autoinhibition. Autophosphorylation
CC       does not alter activity or regulation by Ca(2+)/calmodulin. In part,
CC       activity is independent on Ca(2+)/calmodulin (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with calmodulin. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21957496}. Cytoplasm
CC       {ECO:0000269|PubMed:21957496}. Cell projection, neuron projection
CC       {ECO:0000269|PubMed:21957496}. Note=Predominantly nuclear in
CC       unstimulated cells, relocalizes into cytoplasm and neurites after
CC       forskolin induction. {ECO:0000269|PubMed:21957496}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=Beta1, CAMKK2+E16;
CC         IsoId=Q96RR4-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta2;
CC         IsoId=Q96RR4-2; Sequence=VSP_012146, VSP_012147, VSP_012149;
CC       Name=3; Synonyms=Beta1delta16, CAMKK2-E16;
CC         IsoId=Q96RR4-3; Sequence=VSP_012143, VSP_012144, VSP_012145,
CC                                  VSP_012149;
CC       Name=4; Synonyms=Beta1delta14;
CC         IsoId=Q96RR4-4; Sequence=VSP_012142;
CC       Name=5; Synonyms=Beta1delta14/16, beta-3x;
CC         IsoId=Q96RR4-5; Sequence=VSP_012142, VSP_012143, VSP_012144,
CC                                  VSP_012145, VSP_012149;
CC       Name=6; Synonyms=Beta2delta14;
CC         IsoId=Q96RR4-6; Sequence=VSP_012142, VSP_012146, VSP_012147,
CC                                  VSP_012149;
CC       Name=7;
CC         IsoId=Q96RR4-7; Sequence=VSP_012148, VSP_012149;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with higher levels in the
CC       brain. Intermediate levels are detected in spleen, prostate, thyroid
CC       and leukocytes. The lowest level is in lung.
CC       {ECO:0000269|PubMed:9662074}.
CC   -!- INDUCTION: [Isoform 1]: Up-regulated by PKA pathway.
CC       {ECO:0000269|PubMed:21957496}.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin binding
CC       region and may be involved in intrasteric autoinhibition.
CC   -!- DOMAIN: The RP domain (arginine/proline-rich) is involved in the
CC       recognition of CAMKI and CAMK4 as substrates. {ECO:0000250}.
CC   -!- PTM: Autophosphorylated and phosphorylated by PKA. Each isoform may
CC       show a different pattern of phosphorylation.
CC       {ECO:0000269|PubMed:21957496}.
CC   -!- MISCELLANEOUS: [Isoform 1]: Major isoform.
CC   -!- MISCELLANEOUS: [Isoform 2]: Major isoform. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 5]: Inactive. Does not activate CAMK1 and
CC       CAMK4. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 6]: Inactive. Does not activate CAMK1 and
CC       CAMK4. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC72943.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA34507.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAD38990.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB081337; BAC19841.1; -; mRNA.
DR   EMBL; AF287630; AAK64600.1; -; mRNA.
DR   EMBL; AF287631; AAK64601.1; -; mRNA.
DR   EMBL; AF321385; AAL37215.1; -; mRNA.
DR   EMBL; AF321386; AAL37216.1; -; mRNA.
DR   EMBL; AF321387; AAL37217.1; -; mRNA.
DR   EMBL; AF321388; AAL37218.1; -; mRNA.
DR   EMBL; AF321401; AAK91830.1; -; Genomic_DNA.
DR   EMBL; AF321390; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321391; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321392; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321393; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321394; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321395; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321396; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321397; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321398; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321399; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321400; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321575; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321576; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321577; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321578; AAK91830.1; JOINED; Genomic_DNA.
DR   EMBL; AF321402; AAK91829.1; -; Genomic_DNA.
DR   EMBL; AF321390; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321391; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321392; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321393; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321394; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321395; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321396; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321397; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321398; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321399; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321400; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321575; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321576; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321577; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF321578; AAK91829.1; JOINED; Genomic_DNA.
DR   EMBL; AF140507; AAD31507.1; -; mRNA.
DR   EMBL; AB081336; BAC19840.1; -; mRNA.
DR   EMBL; AB018330; BAA34507.2; ALT_INIT; mRNA.
DR   EMBL; AK292072; BAF84761.1; -; mRNA.
DR   EMBL; AC069209; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000318; AAH00318.2; -; mRNA.
DR   EMBL; BC026060; AAH26060.1; -; mRNA.
DR   EMBL; AF101264; AAD04566.1; -; mRNA.
DR   EMBL; AL834322; CAD38990.1; ALT_SEQ; mRNA.
DR   EMBL; AF091074; AAC72943.1; ALT_INIT; mRNA.
DR   CCDS; CCDS44999.1; -. [Q96RR4-2]
DR   CCDS; CCDS53837.1; -. [Q96RR4-6]
DR   CCDS; CCDS58283.1; -. [Q96RR4-7]
DR   CCDS; CCDS9216.1; -. [Q96RR4-1]
DR   CCDS; CCDS9217.1; -. [Q96RR4-4]
DR   CCDS; CCDS9218.1; -. [Q96RR4-3]
DR   CCDS; CCDS9219.1; -. [Q96RR4-5]
DR   PIR; JE0191; JE0191.
DR   RefSeq; NP_001257414.1; NM_001270485.1. [Q96RR4-1]
DR   RefSeq; NP_001257415.1; NM_001270486.1. [Q96RR4-7]
DR   RefSeq; NP_006540.3; NM_006549.3. [Q96RR4-1]
DR   RefSeq; NP_705719.2; NM_153499.2. [Q96RR4-3]
DR   RefSeq; NP_705720.1; NM_153500.1. [Q96RR4-5]
DR   RefSeq; NP_757363.1; NM_172214.2. [Q96RR4-2]
DR   RefSeq; NP_757364.1; NM_172215.2. [Q96RR4-6]
DR   RefSeq; NP_757365.1; NM_172216.1. [Q96RR4-4]
DR   RefSeq; NP_757380.1; NM_172226.2. [Q96RR4-3]
DR   RefSeq; XP_005253880.1; XM_005253823.1. [Q96RR4-2]
DR   RefSeq; XP_005253881.1; XM_005253824.3. [Q96RR4-5]
DR   RefSeq; XP_011536065.1; XM_011537763.1. [Q96RR4-7]
DR   RefSeq; XP_016874187.1; XM_017018698.1.
DR   RefSeq; XP_016874190.1; XM_017018701.1.
DR   RefSeq; XP_016874191.1; XM_017018702.1. [Q96RR4-7]
DR   RefSeq; XP_016874193.1; XM_017018704.1.
DR   PDB; 2ZV2; X-ray; 2.40 A; A=158-448.
DR   PDB; 5UY6; X-ray; 1.70 A; A=161-449.
DR   PDB; 5UYJ; X-ray; 1.60 A; A=161-449.
DR   PDB; 5VT1; X-ray; 1.90 A; A=161-449.
DR   PDB; 5YV8; X-ray; 1.93 A; A=158-448.
DR   PDB; 5YV9; X-ray; 2.53 A; A=158-448.
DR   PDB; 5YVA; X-ray; 2.57 A; A=158-448.
DR   PDB; 5YVB; X-ray; 2.02 A; A=158-448.
DR   PDB; 5YVC; X-ray; 2.02 A; A=158-448.
DR   PDB; 6BKU; X-ray; 2.00 A; A=162-449.
DR   PDB; 6BLE; X-ray; 1.90 A; A=161-449.
DR   PDB; 6BQL; X-ray; 2.00 A; A=161-449.
DR   PDB; 6BQP; X-ray; 1.95 A; A=161-449.
DR   PDB; 6BQQ; X-ray; 1.80 A; A=161-449.
DR   PDB; 6BRC; X-ray; 2.20 A; A/B=161-449.
DR   PDB; 6CMJ; X-ray; 2.40 A; A/B=149-465.
DR   PDB; 6EF5; X-ray; 2.44 A; Q/S=508-514.
DR   PDB; 6EWW; X-ray; 2.68 A; E/F/G/H=97-104.
DR   PDB; 6FEL; X-ray; 2.84 A; E/F/G/H=508-515.
DR   PDB; 6Y3O; X-ray; 1.50 A; P=97-104.
DR   PDB; 6Y4K; X-ray; 3.00 A; E/F=97-104.
DR   PDB; 6Y6B; X-ray; 3.08 A; C/D=97-104.
DR   PDB; 6Y8A; X-ray; 1.50 A; P=508-515.
DR   PDBsum; 2ZV2; -.
DR   PDBsum; 5UY6; -.
DR   PDBsum; 5UYJ; -.
DR   PDBsum; 5VT1; -.
DR   PDBsum; 5YV8; -.
DR   PDBsum; 5YV9; -.
DR   PDBsum; 5YVA; -.
DR   PDBsum; 5YVB; -.
DR   PDBsum; 5YVC; -.
DR   PDBsum; 6BKU; -.
DR   PDBsum; 6BLE; -.
DR   PDBsum; 6BQL; -.
DR   PDBsum; 6BQP; -.
DR   PDBsum; 6BQQ; -.
DR   PDBsum; 6BRC; -.
DR   PDBsum; 6CMJ; -.
DR   PDBsum; 6EF5; -.
DR   PDBsum; 6EWW; -.
DR   PDBsum; 6FEL; -.
DR   PDBsum; 6Y3O; -.
DR   PDBsum; 6Y4K; -.
DR   PDBsum; 6Y6B; -.
DR   PDBsum; 6Y8A; -.
DR   AlphaFoldDB; Q96RR4; -.
DR   SMR; Q96RR4; -.
DR   BioGRID; 115889; 65.
DR   IntAct; Q96RR4; 31.
DR   STRING; 9606.ENSP00000312741; -.
DR   BindingDB; Q96RR4; -.
DR   ChEMBL; CHEMBL5284; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q96RR4; -.
DR   GuidetoPHARMACOLOGY; 1957; -.
DR   GlyGen; Q96RR4; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q96RR4; -.
DR   PhosphoSitePlus; Q96RR4; -.
DR   BioMuta; CAMKK2; -.
DR   DMDM; 317373374; -.
DR   EPD; Q96RR4; -.
DR   jPOST; Q96RR4; -.
DR   MassIVE; Q96RR4; -.
DR   MaxQB; Q96RR4; -.
DR   PaxDb; Q96RR4; -.
DR   PeptideAtlas; Q96RR4; -.
DR   PRIDE; Q96RR4; -.
DR   ProteomicsDB; 78009; -. [Q96RR4-1]
DR   ProteomicsDB; 78010; -. [Q96RR4-2]
DR   ProteomicsDB; 78011; -. [Q96RR4-3]
DR   ProteomicsDB; 78012; -. [Q96RR4-4]
DR   ProteomicsDB; 78013; -. [Q96RR4-5]
DR   ProteomicsDB; 78014; -. [Q96RR4-6]
DR   ProteomicsDB; 78015; -. [Q96RR4-7]
DR   Antibodypedia; 19059; 394 antibodies from 34 providers.
DR   DNASU; 10645; -.
DR   Ensembl; ENST00000324774.9; ENSP00000312741.5; ENSG00000110931.19. [Q96RR4-1]
DR   Ensembl; ENST00000337174.7; ENSP00000336634.3; ENSG00000110931.19. [Q96RR4-3]
DR   Ensembl; ENST00000347034.6; ENSP00000321230.3; ENSG00000110931.19. [Q96RR4-4]
DR   Ensembl; ENST00000392473.2; ENSP00000376265.2; ENSG00000110931.19. [Q96RR4-2]
DR   Ensembl; ENST00000392474.6; ENSP00000376266.2; ENSG00000110931.19. [Q96RR4-7]
DR   Ensembl; ENST00000402834.8; ENSP00000384591.4; ENSG00000110931.19. [Q96RR4-1]
DR   Ensembl; ENST00000404169.8; ENSP00000384600.3; ENSG00000110931.19. [Q96RR4-1]
DR   Ensembl; ENST00000412367.6; ENSP00000388368.2; ENSG00000110931.19. [Q96RR4-3]
DR   Ensembl; ENST00000446440.6; ENSP00000388273.2; ENSG00000110931.19. [Q96RR4-6]
DR   Ensembl; ENST00000538733.5; ENSP00000445944.1; ENSG00000110931.19. [Q96RR4-5]
DR   Ensembl; ENST00000652382.1; ENSP00000498824.1; ENSG00000110931.19. [Q96RR4-1]
DR   GeneID; 10645; -.
DR   KEGG; hsa:10645; -.
DR   MANE-Select; ENST00000404169.8; ENSP00000384600.3; NM_001270485.2; NP_001257414.1.
DR   UCSC; uc001tzt.4; human. [Q96RR4-1]
DR   CTD; 10645; -.
DR   DisGeNET; 10645; -.
DR   GeneCards; CAMKK2; -.
DR   HGNC; HGNC:1470; CAMKK2.
DR   HPA; ENSG00000110931; Tissue enhanced (brain).
DR   MIM; 615002; gene.
DR   neXtProt; NX_Q96RR4; -.
DR   OpenTargets; ENSG00000110931; -.
DR   PharmGKB; PA26052; -.
DR   VEuPathDB; HostDB:ENSG00000110931; -.
DR   eggNOG; KOG0585; Eukaryota.
DR   GeneTree; ENSGT00940000161828; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; Q96RR4; -.
DR   OMA; NGRCVHP; -.
DR   OrthoDB; 856506at2759; -.
DR   PhylomeDB; Q96RR4; -.
DR   TreeFam; TF313013; -.
DR   BRENDA; 2.7.11.17; 2681.
DR   PathwayCommons; Q96RR4; -.
DR   Reactome; R-HSA-111932; CaMK IV-mediated phosphorylation of CREB.
DR   Reactome; R-HSA-442729; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde.
DR   Reactome; R-HSA-9619229; Activation of RAC1 downstream of NMDARs.
DR   Reactome; R-HSA-9619483; Activation of AMPK downstream of NMDARs.
DR   SignaLink; Q96RR4; -.
DR   SIGNOR; Q96RR4; -.
DR   BioGRID-ORCS; 10645; 15 hits in 1109 CRISPR screens.
DR   ChiTaRS; CAMKK2; human.
DR   EvolutionaryTrace; Q96RR4; -.
DR   GeneWiki; CAMKK2; -.
DR   GenomeRNAi; 10645; -.
DR   Pharos; Q96RR4; Tchem.
DR   PRO; PR:Q96RR4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q96RR4; protein.
DR   Bgee; ENSG00000110931; Expressed in cerebellar cortex and 200 other tissues.
DR   ExpressionAtlas; Q96RR4; baseline and differential.
DR   Genevisible; Q96RR4; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043005; C:neuron projection; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; TAS:UniProtKB.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:UniProtKB.
DR   GO; GO:0032147; P:activation of protein kinase activity; IBA:GO_Central.
DR   GO; GO:0019722; P:calcium-mediated signaling; TAS:UniProtKB.
DR   GO; GO:0061762; P:CAMKK-AMPK signaling cascade; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0000165; P:MAPK cascade; TAS:UniProtKB.
DR   GO; GO:1903599; P:positive regulation of autophagy of mitochondrion; IC:ParkinsonsUK-UCL.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; TAS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0045859; P:regulation of protein kinase activity; TAS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Calmodulin-binding; Cell projection; Cytoplasm; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..588
FT                   /note="Calcium/calmodulin-dependent protein kinase kinase
FT                   2"
FT                   /id="PRO_0000086144"
FT   DOMAIN          165..446
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          78..100
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          128..149
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          204..226
FT                   /note="RP domain"
FT   REGION          205..225
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          472..477
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000250"
FT   REGION          475..500
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          497..588
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        82..100
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        128..142
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        523..540
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        312
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         171..179
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         194
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C078"
FT   MOD_RES         114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         129
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         133
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C078"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C078"
FT   MOD_RES         495
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         511
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         572
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C078"
FT   VAR_SEQ         442..484
FT                   /note="Missing (in isoform 4, isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:11395482,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012142"
FT   VAR_SEQ         520..532
FT                   /note="KPTRECESLSELK -> QGSEDNLQGTDPP (in isoform 3 and
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11395482,
FT                   ECO:0000303|PubMed:12935886, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012143"
FT   VAR_SEQ         533..554
FT                   /note="EARQRRQPPGHRPAPRGGGGSA -> GTKKKKGLDSMTSTVAAGWLDRRV
FT                   (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|PubMed:9872452"
FT                   /id="VSP_012148"
FT   VAR_SEQ         533..541
FT                   /note="EARQRRQPP -> PVGEEEVLL (in isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11395482,
FT                   ECO:0000303|PubMed:12935886, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012144"
FT   VAR_SEQ         533
FT                   /note="E -> T (in isoform 2 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:11395482,
FT                   ECO:0000303|PubMed:9662074, ECO:0000303|Ref.11"
FT                   /id="VSP_012146"
FT   VAR_SEQ         534..554
FT                   /note="Missing (in isoform 2 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:11395482,
FT                   ECO:0000303|PubMed:9662074, ECO:0000303|Ref.11"
FT                   /id="VSP_012147"
FT   VAR_SEQ         542..554
FT                   /note="Missing (in isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11395482,
FT                   ECO:0000303|PubMed:12935886, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012145"
FT   VAR_SEQ         555..588
FT                   /note="Missing (in isoform 2, isoform 3, isoform 5, isoform
FT                   6 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:11395482,
FT                   ECO:0000303|PubMed:12935886, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|PubMed:9662074, ECO:0000303|PubMed:9872452,
FT                   ECO:0000303|Ref.11"
FT                   /id="VSP_012149"
FT   VARIANT         10
FT                   /note="S -> N (in dbSNP:rs28360477)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032788"
FT   VARIANT         85
FT                   /note="T -> S (in dbSNP:rs3817190)"
FT                   /evidence="ECO:0000269|PubMed:11395482,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:9872452"
FT                   /id="VAR_020532"
FT   VARIANT         123
FT                   /note="C -> Y (in dbSNP:rs35403710)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040610"
FT   VARIANT         127
FT                   /note="P -> L (in a lung neuroendocrine carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040611"
FT   VARIANT         182
FT                   /note="A -> T (in a colorectal adenocarcinoma sample;
FT                   somatic mutation; dbSNP:rs1207121718)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040612"
FT   VARIANT         363
FT                   /note="R -> C (in dbSNP:rs1132780)"
FT                   /id="VAR_020533"
FT   VARIANT         492
FT                   /note="R -> H (in dbSNP:rs34129994)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040613"
FT   CONFLICT        206
FT                   /note="G -> A (in Ref. 2; AAD31507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        331
FT                   /note="F -> I (in Ref. 6; BAF84761)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        347
FT                   /note="T -> Y (in Ref. 2; AAD31507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        371
FT                   /note="L -> K (in Ref. 2; AAD31507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        554
FT                   /note="A -> H (in Ref. 1; AAK91829)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        557
FT                   /note="R -> N (in Ref. 1; AAK91829)"
FT                   /evidence="ECO:0000305"
FT   STRAND          165..172
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   STRAND          175..184
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   TURN            185..188
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   STRAND          189..197
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   HELIX           198..204
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   HELIX           231..242
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   STRAND          251..256
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   STRAND          260..268
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   STRAND          273..275
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   HELIX           286..305
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   HELIX           315..317
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   STRAND          318..320
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   STRAND          326..328
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   STRAND          338..341
FT                   /evidence="ECO:0007829|PDB:5UY6"
FT   STRAND          343..346
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   HELIX           351..353
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   HELIX           356..358
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   STRAND          364..367
FT                   /evidence="ECO:0007829|PDB:6CMJ"
FT   HELIX           368..385
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   HELIX           395..404
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   STRAND          411..413
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   HELIX           417..426
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   TURN            431..433
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   HELIX           437..440
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   HELIX           444..447
FT                   /evidence="ECO:0007829|PDB:5UYJ"
FT   TURN            448..451
FT                   /evidence="ECO:0007829|PDB:6CMJ"
FT   HELIX           457..461
FT                   /evidence="ECO:0007829|PDB:6CMJ"
FT   MOD_RES         Q96RR4-3:522
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         Q96RR4-5:479
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
SQ   SEQUENCE   588 AA;  64746 MW;  04E3583561341167 CRC64;
     MSSCVSSQPS SNRAAPQDEL GGRGSSSSES QKPCEALRGL SSLSIHLGME SFIVVTECEP
     GCAVDLGLAR DRPLEADGQE VPLDTSGSQA RPHLSGRKLS LQERSQGGLA AGGSLDMNGR
     CICPSLPYSP VSSPQSSPRL PRRPTVESHH VSITGMQDCV QLNQYTLKDE IGKGSYGVVK
     LAYNENDNTY YAMKVLSKKK LIRQAGFPRR PPPRGTRPAP GGCIQPRGPI EQVYQEIAIL
     KKLDHPNVVK LVEVLDDPNE DHLYMVFELV NQGPVMEVPT LKPLSEDQAR FYFQDLIKGI
     EYLHYQKIIH RDIKPSNLLV GEDGHIKIAD FGVSNEFKGS DALLSNTVGT PAFMAPESLS
     ETRKIFSGKA LDVWAMGVTL YCFVFGQCPF MDERIMCLHS KIKSQALEFP DQPDIAEDLK
     DLITRMLDKN PESRIVVPEI KLHPWVTRHG AEPLPSEDEN CTLVEVTEEE VENSVKHIPS
     LATVILVKTM IRKRSFGNPF EGSRREERSL SAPGNLLTKK PTRECESLSE LKEARQRRQP
     PGHRPAPRGG GGSALVRGSP CVESCWAPAP GSPARMHPLR PEEAMEPE
//
